Craig Beeson to T-Lymphocytes
This is a "connection" page, showing publications Craig Beeson has written about T-Lymphocytes.
Connection Strength
0.753
-
Utility of azapeptides as major histocompatibility complex class II protein ligands for T-cell activation. J Med Chem. 2001 Oct 25; 44(22):3700-9.
Score: 0.143
-
Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity. Cell Rep. 2019 08 13; 28(7):1879-1893.e7.
Score: 0.122
-
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
Score: 0.116
-
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
Score: 0.108
-
Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface. J Exp Med. 1996 Aug 01; 184(2):777-82.
Score: 0.099
-
Involvement of calpain in the process of Jurkat T cell chemotaxis. J Neurosci Res. 2009 Feb 15; 87(3):626-35.
Score: 0.059
-
Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity. J Exp Med. 2003 May 19; 197(10):1391-7.
Score: 0.040
-
Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers. Biochemistry. 1999 Dec 14; 38(50):16663-70.
Score: 0.031
-
Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity. 1998 May; 8(5):571-80.
Score: 0.028
-
Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. Immunity. 1998 Oct; 9(4):459-66.
Score: 0.007